Lb Pharmaceuticals Inc filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-15. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
On September 15, 2026, LB Pharmaceuticals Inc (the "Company") announced that Susan G. Kozauer, M.D. has been appointed to serve as the Company's Chief Medical Officer, effective as of September 14, 2026 (the "Start Date").
Appointed: Joseph M. Miller, Chief Financial Officer, effective 2026-09-02
On September 3, 2026, LB Pharmaceuticals Inc (the "Company") announced that Joseph M. Miller has been appointed to serve as the Company's Chief Financial Officer, effective as of September 2, 2026 (the "Start Date").
Reported
On June 8, 2026, she resigned from her position as Chief Medical Officer of the Company effective June 15, 2026 (the " Separation Date ").
Find people with the same kind of experience as the Chief Financial Officer at Lb Pharmaceuticals Inc, with the record behind each one.
Find candidates like Chief Financial Officer at Lb Pharmaceuticals IncNew leaders review vendors and budgets in their first months. Get an alert the next time Lb Pharmaceuticals Inc is in the news or changes leadership.
Get an alert when Lb Pharmaceuticals Inc changes leadershipTools for this story
Each opens in a new tab, filled in for Lb Pharmaceuticals Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.